Actavis UK appoints Otago Healthcare to develop strategy for new in-licensed Cardiology product
Otago Healthcare to launch IPC Pharma in the UK & Eire
April 30, 2008Official launch of IPC Pharma Limited in the UK held at Danish Embassy, London
September 1, 2008Actavis UK appoints Otago Healthcare to develop strategy for new in-licensed Cardiology product
Actavis,(second largest generic supplier in the UK) appoints Otago Healthcare to design and implement global training programme on Thrombolysis and Rapilysin.
Actavis purchased the global rights to this thrombolytic from Roche Products. The initial strategy will be to look at switching key hospital units in Scotland where Rapilsyn had historically a strong market share.